Photo: Microscope close up

Ozanimod

Ozanimod (RPC-1063) is a tablet being developed for relapsing MS. It is currently in phase 3 clinical trials and is produced by Celgene.

Current phase of trial: phase 3

Type of MS: relapsing MS

Find out more about ozanimod